Inventor · disambiguated record
Jane V. Aldrich
Also filed as: ALDRICH JANE · ALDRICH JANE V
7 granted patents·6 pending applications·22 citations·filing 2002–2021
79Inventor score
Top patents by PatentIndex Score
13 records- 0180US10259843B2Cyclic tetrapeptide stereoisomersUNIV KANSAS·Filed 2015·Granted Apr 16, 2019·5 cites·17 claims
- 0275US7038078B2Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acidUNIV MARLYLAND BALTIMORE·Filed 2002·Granted May 2, 2006·10 cites·36 claims
- 0373US8809278B2Cyclic tetrapeptidesALDRICH JANE V·Filed 2009·Granted Aug 19, 2014·7 cites·24 claims
- 0461US10988506B2Cyclic tetrapeptide stereoisomersUNIV KANSAS·Filed 2019·Granted Apr 27, 2021·0 cites·15 claims
- 0561US2022048946A1Cyclic tetrapeptide stereoisomersUNIV KANSAS·Filed 2021·Application pending·0 cites
- 0656US11510964B2Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growthUNIV KANSAS·Filed 2020·Granted Nov 29, 2022·0 cites·20 claims
- 0750US11820835B2Cyclic tetrapeptide analogsUNIV KANSAS·Filed 2019·Granted Nov 21, 2023·0 cites·17 claims
- 0849US2024109936A1Novel macrocyclic opioid peptidesUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 0947US11325944B2Macrocyclic peptides and derivatives thereof with opioid activityUNIV FLORIDA·Filed 2018·Granted May 10, 2022·0 cites·26 claims
- 1046US2005187407A1Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acidFiled 2005·Application pending·0 cites
- 1146US2019388499A1Macrocyclic peptides to decrease c-myc protein levels and reduce cancer cell growthUNIV KANSAS·Filed 2018·Application pending·0 cites
- 1244US2021163532A1Novel macrocyclic opioid peptidesUNIV FLORIDA·Filed 2019·Application pending·0 cites
- 1340US2009111741A1Method for treating and/or preventing drug seeking behaviorALDRICH JANE V·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jane V. Aldrich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →